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Abstract:
Infertility is defined as the inability of a sexually active, non-contraceptive couple to achieve spontane-
ous pregnancy within one year (Word Health Organisation). It is estimated that there are 15-20% of 
infertile couples, and this number is increasing, making infertility a major socio-demographic global 
problem. In the past, female factors were thought to be the main causes, but today we know that male 
infertility accounts for about 50% of cases. Therefore, simultaneous treatment of both sexes is recom-
mended.
The most severe condition of male infertility is azoospermia, which occurs in the general population in 
1%, while in infertile male populations it occurs in 10-20% of cases. Azoospermia can be obstructive 
(OA) and non-obstructive (NOA). Among various treatment options for azoospermia, testicular bi-
opsy (TESE) provides the best chance of sperm retrieval. TESE can be done by classical (conventional, 
open) approach or using an operating microscope, microsurgical TESE (mTESE). mTESE is reserved 
for the most complex patients with genetic disorders or previously sperm retrieval failure during con-
ventional TESE procedure.
Keywords: infertility, azoospermia, open testicular biopsy (TESE), microsurgical TESE (mTESE), 
cryopreservation, urology
Sažetak:
Konvencionalna TESE: Kratki pregled i devetogodišnje iskustvo jednog centra
Neplodnost je nemogućnost postizanja spontane trudnoće seksualno aktivnog para koji ne koristi 
kontracepciju u roku od jedne godine (Svjetska zdravstvena organizacija). Procjenjuje se da ima 
15-20% neplodnih parova i taj se postotak povećava, što neplodnost čini važnim, globalnim socio-
demografskim problemom. U prošlosti se smatralo kako je ženska neplodnost češća, ali danas znamo 
da polovicu slučajeva čine muškarci. Stoga se preporučuje istovremena obrada i liječenje oba spola.
Najteži oblik muške neplodnosti je azoospermija, koja se u općoj populaciji javlja u 1% muškaraca, 
dok se u neplodne muške populacije javlja u 10-20% slučajeva. Azoospermija može biti opstruktivna 
(OA) i neopstruktivna (NOA). Među različitim mogućnostima liječenja azoospermije, biopsija testisa 
(TESE) pruža najbolje šanse za pronalazak spermija. TESE se može izvesti klasičnim (konvencional-
nim, otvorenim) pristupom ili uporabom operacijskog mikroskopa, mikrokirurška TESE (mTESE). 
mTESE se koristi kod najsloženijih pacijenata s genetskim poremećajima ili prethodno neuspjelim 
pronalaženjem spermija tijekom uobičajenog TESE postupka.
Ključne riječi: neplodnost, azoospermija, otvorena biopsija sjemenika (TESE), mikrokirurška 
TESE (mTESE), krioprezervacija, urologija
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Infertility in men, as defined by the World Health Organization, 
is a condition in which a man has not conceived a child for 12 
months (without the use of contraceptive). It is estimated that in 
the Republic of Croatia, as in other European Union countries, 
15-20% of couples are infertile or have problems conceiving, 
and male infertility is responsible for 20-50% of cases. The most 
severe form of infertility is the complete absence of sperm in 
the semen, which is defined as azoospermia, and occurs in the 
general population in 1%, while in infertile men it occurs in 10-
20% of cases. 1-3 Azoospermia can be obstructive (OA) and non-
obstructive (NOA), the latter usually has a more severe form. 1 
The etiology of male infertility is unclear and although there are 
some diseases, some environmental factors, as well as some eating 
and psychological disorders that may be associated with infertil-
ity, in 70-90% of cases it is unknown 4. A significant number of 
patients (30-40%) did not have diseases that could affect fertility, 
moreover, they have normal findings on physical examination, 
as well as endocrine, genetic and biochemical laboratory tests, 
i.e. there is no male factor to explain the pathological finding of 
semen. For these patients we can use the term idiopathic male 
infertility. In most cases, patients or couples (which is considered 
a better option) are referred to a urologist or andrology subspe-
cialist when an abnormal semen analysis is found at the gy-
necologist. A detailed medical history and physical examination 
are usually the first step, followed by at least two semen analysis, 
determination of hormone levels (Follicle-stimulating hormone 
(FSH), luteinizing hormone (LH), testosterone, prolactin, 
estradiol, thyroid stimulating hormone (TSH), thyroxine (T4), 
sex hormone binding globuine (SHBG)), urine and semen bacte-
rial testing, testicular ultrasound and genetic analysis (karyotype, 
Y chromosome microdeletion and cystic fibrosis). Sometimes 
further testing based on these findings is needed 5 Various 
techniques can be used in patients diagnosed with azoospermia, 
such as percutaneous sperm aspiration (PESA), microsurgical 
epididymal sperm aspiration (MESA), testicular sperm aspiration 
(TESA), testicular sperm extraction (TESE) and microsurgical 
testicular sperm extraction (mTESE). The best sperm retrieval 
rate is achieved by TESE and mTESE techniques, and the most 
common histological finding in these patients is “mixed atro-
phy”, the presence of normal seminiferous tubules mixed with 
atrophic tubules.
Conventional TESE procedure
Conventional TESE is usually performed as an outpatient 
procedure. After the preparation of the operative field and local 
anesthesia, an incision of the skin and subcutaneous tissue and 
exposure of the testis is performed, followed by the incision of 
tunica albuginea on three different parts (upper, middle and low-
er) to increase the possibility of positive sperm findings according 
to the European Academy of Urology (Figure 1). Patients are 
discharged from the hospital the same afternoon. They should 
rest for a few days, and a full recovery is expected in 14 days.
Immediately after harvesting testicular tissue, embryologist be-
gins microdissection of tissue under sterile conditions in laminar 
flow (Figure 2). Each piece of tissue is divided into two parts. 
The first part is immersed in cryo-medium as a preparation for 
the deep-freezing procedure, and the second part is prepared for 
a detailed pathohistological examination. The deep-freezing tis-
sue is programmably frozen and stored in a container with liquid 
nitrogen. Tissue for pathohistological analysis (PHA) is fixed 
and stained with hematoxylin eosin and immunohistochemically 
(IHC), then a detailed pathohistological analysis is performed. 
PHA was scored using the Johnsen International Scoring System 
to analyze the degree of preservation of spermatogenesis, from 
0-10. Zero is the worst value and means that only fibrotic tissue 
was found, and ten is the best value and means full spermato-
genesis. The higher the score the greater the chance of successful 
intracytoplasmic sperm injection/in vitro fertilisation (ICSI/IVF) 
procedures, ideally a score of nine and ten is the best (Table 1) 24. 
To avoid unexpected genetic abnormalities, only sperm should 
be used in the ICSI/IVF procedure, not spermatids. Immunohis-
tochemical staining is very important because in these patients 
the probability of germ cell neoplasia in situ (GCNIS) is one 
hundred times higher. 
mTESE procedure
Microsurgical testicular sperm extraction (mTESE) was first 
described by Schlegel in 1999 6 as an advanced microsurgi-
cal treatment assisted with operating microscope for retrieving 
sperm from men with NOA. 7 Some recent studies suggests that 
mTESE is 1.5-fold better at sperm extraction than conventional 
TESE when harvesting random multiple biopsies at three dif-
ferent parts of the testis. It is also twice as effective as testicular 
aspiration (TESA) in controlled trials. 8 Spermatogenesis does 
not show homogeneity in all parts of the testis, moreover, most 
seminiferous tubules in NOA do not show normal stratification 
and germ cells count, but only small, thin tubules that do not 
contain sperms or any form of normal spermatogenesis. How-
ever, under 20–25-fold microscopic magnification with precise 
microdissection, seminal tubules with full spermatogenesis are 
more easily identified. These tubules are larger and most opaque 
on microscopic appearance and are therefore different from the 
surrounding tubules. Using an inverted microscope they can 
be promptly analysed for the presence of sperm. This led to 
the identification of sperm in 63% of men using the mTESE 
technique, compared to 45% of sperm retrieval using the con-
ventional TESE technique in the original publication. However, 
both methods have advanced over the years and numerous 
studies have been made that compare them. Corona et al i 2019. 
performed a systematic review and meta-analysis and found 
no differences when mTESE was compared with conventional 
TESE (46[43;49]% for TESE versus 46[42;49]% for mTESE) 
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and in general we can say that they are similar with a sperm 
retrieval rate around 50%. 9 
There is always a question which method is better for which 
patients, i.e. which patients can benefit from mTESE procedure? 
Many factors such as the patient’s age, hormone levels, testicular 
volume, and previous surgical procedures influence the choice 
of procedure. If TESE did not result in a satisfactory sperm 
retrieval rate, we can try the mTESE, but even mTESE cannot 
retrieve sperm in patients with severely damaged testicles like 
patients with Klinefelter syndrome. To clarify which technique is 
superior, we need a sufficiently strong and well-designed prospec-
tive, multicentric and randomized controlled study to compare 
mTESE to TESE in men with NOA.
Some patients have a combination of varicocele and azoospermia 
and the question is whether they can benefit from varicocelecto-
my (VR). Esteves et al. performed a meta-analysis evaluating the 
role of VR in men with NOA and concluded that VR may be 
associated with sperm appearance in the postoperative ejaculate 
and may affect surgical sperm retrieval rate. 10 However, there 
are biases in many of the studies analyzed, moreover, the results 
of varicocele repair can be observed only after 3-6 months. 11 
Also, some results suggest that 10-18% of men with NOA will 
have sperms in ejaculate with control semen analysis without any 
surgical intervention for varicocele. Many patients have female 
partners in their late thirties or early forties and do not want any 
prolongation of a possible child conceiving and choose immedi-
ate sperm retrieval technique without waiting for possible sperm 
recovery after VR. 12-22
Almost all patients with NOA have abnormal sex hormone find-
ings. In most of them, FSH levels are high, while LH levels and 
testosterone levels are normal, but for those with lower testoster-
one levels, adjuvant hormone therapy may be helpful. Hussein et 
al. in a prospective, multicentric study in 42 patients with NOA 
and a histopathological diagnosis of maturation arrest or hypo-
spermatogenesis, used clomiphene citrate for 3–9 months at a dose 
of 25 mg/d to 75 mg/d. Semen analyses showed that in 64.3% of 
men the sperm concentration increased to an average of 3.8 mil-
lion/mL. 23 In addition to clomiphene citrate, aromatase inhibi-
tors can be used, depending on the testosterone/estradiol (T:E2) 
ratio. For example, if T:E2 was <10, 1 mg of anastrozole daily is 
advised. For men with an inadequate testosterone response, added 
injections of human chorionic gonadotropin (hCG) at a dose of 
1,500 IU subcutaneously two or three times a week may be given. 
Depending on the pathohistological findings during previous 
conventional TESE procedure, some patients might benefit from 
150 IU human recombinant follicle stimulating hormone (rFSH) 
substitution two or three times a week for several months before 
a new mTESE procedure is performed, especially if FSH levels 
are normal and PHE result suggests spermatide stop. However, 
recently published papers have shown conflicting results, namely a 
failure of the sperm retrieval rate 3. Therefore, care should be taken 
when deciding which therapy should be given to the patient.
 
Figure 1. “Open” testicular biopsy. The assistant holds the testicle in a fixed position 
while the operator uses a scalpel to approach the parenchyma of the testis, which gently 
protrudes through the incision of the tunica albuginea.
 
Figure 2. Shows tissue microdissection in laminar flow.
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Score Histological criteria
10 Full spermatogenesis
9 Slightly impaired spermatogenesis, many late spermatids, disorganized epithelium
8 Less than five spermatozoa per tubule, few late spermatids
7 No spermatozoa, no late spermatids, many early spermatids
6 No spermatozoa, no late spermatids, few early spermatids
5 No spermatozoa or spermatids, many spermatocytes
4 No spermatozoa or spermatids, few spermatocytes
3 Spermatogonia only
2 No germinal cells, Sertoli cells only
1 No seminiferous epithelium
NOA All (NOA+OA)
No patients 302 (90%) 336
Spermatozoa 163 (54%) 198 (59%)
Late spermatids 39 (13%) 37 (11%)
Table 1. Johnsen score
Table 2. Our results showing number of spermatozoa and spermatids in all and NOA patients. 
Our experience
At the University Hospital Centre Zagreb, we have established 
the Centre for reproductive medicine and andrology in 2015, 
which unites many departments (mainly urology and gynaecol-
ogy) that help infertile couples. Our centre is accredited by the 
European Academy of Andrology. We started the TESE proce-
dure in 2013, and so far in 9 years we have performed a total 
of 336 procedures in collaboration with School of Medicine 
Zagreb, Department for histology and embryology. All harvested 
testicular tissue is stored in liquid nitrogen in the Department 
for tissue banking. We had 90% of patients with NAO and 10% 
with OA, with a sperm retrieval success rate of 59%, which is 
comparable with well recognised infertility world centres. When 
we analysed patients with NOA, we found sperms in 54% of 
patients and late spermatids in 13% of patients (Table 2). These 
good sperm retrieval rates are achieved by using multiple inci-
sions on each testis. Complications are rare and we observed only 
three scrotal haematomas and four wound infections.
There are patients with a previous failure of sperm retrieval during 
TESE procedure, and also patients with genetic disorders such as 
Klinefelter syndrome who could benefit from mTESE procedure. 
This demanding and time-consuming technique should be offered 
to carefully selected patients. With this technique less tissue will be 
harvested for best results. We are still not performing this proce-
dure, but we are planning to do it in the near future. 
Conlusion
Male infertility is becoming an increasing demographic problem. 
Sperm retrieval techniques are the only possibility for biologi-
cal child conceiving in patients with diagnosed azoospermia. In 
more than half of our patients, we found sperm that could be 
used in the combined ICSI / IVF procedure, which could enable 
them to become biological fathers/parents, and which would 
have been impossible without this technique. For highly selected 
patients in whom TESE has failed, we can offer more advanced 
sperm finding techniques such as mTESE. Further research and 
advances in a very important area of  tissue culture are likely to 
help even more azoospermic patients in the future.
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